EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactate Activates the HCAR1/β‐Arrestin2/PP2A Signaling Axis to Mediate STAT1/2 Dephosphorylation and Drive Osteosarcoma Progression

Zhitao Han, Qi Jia, Guangjian Bai, Zhao Li, Jin Zeng, Zhenhua Wang, Jing Zhang, Jiashi Cao, Baoquan Xin, Yonggang Liu, Jingyu Shen, Lining Wang und 15 weitere

Advanced Science · 2025-12 · 12 (45)

DOI: 10.1002/advs.202506214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.09.2025. Verfasst von Zhitao Han und 26 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China. Hauptthemen laut MEDLINE: Osteosarcoma, beta-Arrestin 2, Lactic Acid, Protein Phosphatase 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Matching Foundation of National Natural Science Foundation of China, Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The “Warburg effect”, a hallmark of Osteosarcoma(OS), results in lactate accumulation due to aerobic glycolysis. The role and underlying mechanisms of lactate in OS are not well understood. Herein, the lactate‐activated hydroxycarboxylate receptor 1(HCAR1) is found to promote OS progression via inhibiting the transcription of anti‐oncogene downstream of STAT1/2. The phosphorylation level of STAT1/2 holds considerable significance for transcriptional activity. In this study, protein phosphatase 2A(PP2A) is identified as the tyrosine phosphatase of STAT1/2. Lactate‐activated HCAR1, facilitating PP2A interaction with phosphorylated STAT1/2 via β‐Arrestin 2, resulting in STAT1/2 dephosphorylation, a key process linked to the aggressive behavior of OS. Using PP2A inhibitor Endothall can abolish the dephosphorylation effect of HCAR1 on STAT1/2, inhibit cancer cell proliferation, migration, and cell cycle, and promote apoptosis. Moreover, the combination of Endothall and Cisplatin is high synergistic in treating OS. In conclusion, the study elucidates the pro‐oncogenic role of lactate‐activated HCAR1 in OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteosarcomabeta-Arrestin 2Lactic AcidProtein Phosphatase 2STAT1 Transcription FactorReceptors, G-Protein-CoupledBone NeoplasmsSTAT2 Transcription FactorHumansPhosphorylationSignal TransductionCell Line, TumorCell ProliferationDisease ProgressionAnimalsMice

Stichwörter der Autor:innen

HCAR1STAT1/2lactateosteosarcomaβ‐Arrestin 2

Substanzen

beta-Arrestin 2Lactic AcidProtein Phosphatase 2STAT1 Transcription FactorHCAR1 protein, humanReceptors, G-Protein-CoupledSTAT1 protein, humanSTAT2 Transcription Factor

Autor:innen und Institutionen

  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
  • Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210022, China.
  • Department of Orthopaedic Oncology, The Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
  • School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200090, China.
  • Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China.
  • Department of Centre for Translational Medicine, The Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.

ORCID-Profile: Tielong Liu

Förderung

  • National Natural Science Foundation of China
  • The Matching Foundation of National Natural Science Foundation of China
  • Shanghai Rising-Star Program
  • Nanjing Young Talents Project of Traditional Chinese Medicine
  • General program of the Natural Science Foundation of Guangxi

Zitieren

APA

Han, Z., Jia, Q., Bai, G., Li, Z., Zeng, J., Wang, Z., Zhang, J., Cao, J., Xin, B., Liu, Y., Shen, J., Wang, L., Huang, X., Zhang, C., Tong, K., Dai, F., Zhang, Y., Zhu, W., Cheng, S., …, & Liu, T. (2025). Lactate Activates the HCAR1/β‐Arrestin2/PP2A Signaling Axis to Mediate STAT1/2 Dephosphorylation and Drive Osteosarcoma Progression. Advanced Science, 12(45). https://doi.org/10.1002/advs.202506214

Vancouver

Han Z, Jia Q, Bai G, Li Z, Zeng J, Wang Z, et al. Lactate Activates the HCAR1/β‐Arrestin2/PP2A Signaling Axis to Mediate STAT1/2 Dephosphorylation and Drive Osteosarcoma Progression. Advanced Science. 2025;12(45). doi:10.1002/advs.202506214

BibTeX
@article{Han2025,
  author = {Han, Zhitao and Jia, Qi and Bai, Guangjian and Li, Zhao and Zeng, Jin and Wang, Zhenhua and Zhang, Jing and Cao, Jiashi and Xin, Baoquan and Liu, Yonggang and Shen, Jingyu and Wang, Lining and Huang, Xing and Zhang, Chunlei and Tong, Kai and Dai, Fenglei and Zhang, Yajie and Zhu, Weina and Cheng, Songyi and Chen, Yuanming and Yang, Xinghai and Chen, Guanghui and Zhou, Zhenhua and Ma, Yong and Liu, Weibo and Wang, Ting and Liu, Tielong},
  title = {Lactate Activates the HCAR1/β‐Arrestin2/PP2A Signaling Axis to Mediate STAT1/2 Dephosphorylation and Drive Osteosarcoma Progression},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {45},
  doi = {10.1002/advs.202506214}
}
Kostenlos starten →